Full Text
PAR5 COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRATM) IN THE TREATMENT OF US PATIENTS WITH RHEUMATOID ARTHRITIS (RA)

Abstract

Authors

N Bansback A Brennan N Sengupta

Back to Volume 7, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×